about
Substrates and products of eosinophil peroxidaseMechanism of nitrite oxidation by eosinophil peroxidase: implications for oxidant production and nitration by eosinophilsPreparation and Characterization of a Polyclonal Antibody against Brominated ProteinCharacterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR85-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2).Pharmacology and Clinical Drug Candidates in Redox MedicineStructural Basis for Promutagenicity of 8-Halogenated GuanineKinetics of peroxidases in guinea pig bone marrow under immunostimulationBromine is an essential trace element for assembly of collagen IV scaffolds in tissue development and architectureToxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitroElevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesionsIncreased atherosclerosis in myeloperoxidase-deficient miceThe principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory statesPeroxidative metabolism of carcinogenic N-arylhydroxamic acids: implications for tumorigenesisProtein Radical Formation Resulting from Eosinophil Peroxidase-catalyzed Oxidation of SulfiteTaurine Bromamine: Reactivity of an Endogenous and Exogenous Anti-Inflammatory and Antimicrobial Amino Acid DerivativeProduction of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation.Oxidative risk for atherothrombotic cardiovascular disease.Redox control of asthma: molecular mechanisms and therapeutic opportunities.Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase.Evaluation of Serum 3-Bromotyrosine Concentrations in Dogs with Steroid-Responsive Diarrhea and Food-Responsive DiarrheaEosinophil-dependent bromination in the pathogenesis of asthmaNeutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis.Effects of hypochlorite on cultured respiratory epithelial cells.Role of eosinophil peroxidase in the origins of protein oxidation in asthma.Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize alpha-amino acids to a family of reactive aldehydes. Mechanistic studies identifying labile intermediates along the reaction pathway.Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors.Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue.Oxidative modification of proteins: an emerging mechanism of cell signaling.High dissociation rate constant of ferrous-dioxy complex linked to the catalase-like activity in lactoperoxidase.Mutagenic consequences of cytosine alterations site-specifically embedded in the human genome.Epigenetics of chronic rhinosinusitis and the role of the eosinophil.Antioxidant responses to oxidant-mediated lung diseases.Stability of 3-bromotyrosine in serum and serum 3-bromotyrosine concentrations in dogs with gastrointestinal diseases.Eosinophils generate brominating oxidants in allergen-induced asthma.Reactive oxygen species in cardiovascular disease.Disruption of heme-peptide covalent cross-linking in mammalian peroxidases by hypochlorous acid.Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver.Cytophilic and cytotoxic properties of human eosinophil peroxidase plus major basic proteinThe Ancient Immunoglobulin Domains of Peroxidasin Are Required to Form Sulfilimine Cross-links in Collagen IV
P2860
Q24533401-9F7FE4EE-3B29-46F2-8AE1-2140E0A03F6FQ24541441-3C71109E-F3E7-47CE-BD87-7B46F7670447Q24654224-DCC8215F-AE0C-4C22-8524-31D80001E73BQ24674581-C68AD836-5A22-45B5-8D8B-5DACE1334724Q24794741-CF65C08F-3280-459D-AFE7-02357CE0BC78Q26785525-319C7671-3425-4E55-A2DD-D4C0F9B69105Q27681348-765F6CF1-AA57-4827-863D-541E7AC144A4Q28118976-C5A55E9B-063D-493E-B97B-DB7943AD5EACQ28241536-56937B5E-A928-4428-A892-313CAFF0E076Q28284666-0FF813BB-4708-4D49-9590-87E033A17B06Q28344995-ECCEB484-F58D-4A3A-86EE-A409AF317D33Q28350068-BC33BBED-1554-4C03-A198-F8720E66A870Q28396048-4F8F29A1-BF3B-4BED-9A3B-C8297CCE361EQ28679235-4E229100-3A7D-4C99-9AB5-B62205EB5285Q28750158-A565C4C3-ED6B-41DB-9D76-1A1980B05025Q28828997-A8F5EBBE-B126-4D63-AB84-7F2471C927A9Q31628322-59CED408-CD89-44B4-901C-50F85C4ED88BQ33554184-B9E502AA-61AC-403E-BFD1-FD5C2FACDCFCQ33668491-4D898FD4-1C43-40D1-9B07-498AAFFB646DQ33818264-FF3574E7-891D-417A-A4FA-ACCC8121B807Q33900097-491D2495-D314-4903-BA31-B7227A81C83CQ33919164-01747CAA-1370-4B0E-AE2C-CAC9A1D761AEQ33947266-B663B887-99B8-4066-9119-84D8BBEC19F6Q33948695-FACFB935-0F17-4B9A-829C-50589125A828Q34037726-6AFB5416-C0D4-4253-8080-41A0FD0EA86FQ34066009-6B0C1A39-D2B3-44F7-B3C1-ADC7CE7A8FC4Q34094945-86E16360-AFA4-4BB8-9EEF-D915DDE2885DQ34191993-2FDDA025-F59E-4A1B-944B-DABC59812F2EQ34304903-A56995F4-27AA-4AFC-86BA-914DFE3CD32EQ34333942-60692A28-CB12-4300-8532-C74D83D2E9A3Q34539257-B8134FAC-EEAF-45A4-A62C-425D51C62F01Q34562625-C0F522C9-B436-4AF2-8E9D-C51ADF05DE8EQ34735411-9A615813-2206-42D6-9C2A-F0684FEA31BDQ34987829-F0B3B436-A108-4BF0-8B90-84F507B9D3ECQ35160027-96D7E64F-A631-4081-A8C4-33D77991B42DQ35165194-83CF9C41-4BAB-4E86-9FDA-3C749D6F364AQ35668057-7C1AB95D-295B-403F-9FD6-95EF670979A0Q35747219-E073D60C-F7D8-47AD-8532-A6642841318DQ35818956-81064A92-8181-42D0-BDCE-499D42D6A364Q36065146-B76FA109-08BC-44AF-8577-4A10CD91380C
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Brominating oxidants generated by human eosinophils.
@en
Brominating oxidants generated by human eosinophils.
@nl
type
label
Brominating oxidants generated by human eosinophils.
@en
Brominating oxidants generated by human eosinophils.
@nl
prefLabel
Brominating oxidants generated by human eosinophils.
@en
Brominating oxidants generated by human eosinophils.
@nl
P2093
P356
P1433
P1476
Brominating oxidants generated by human eosinophils.
@en
P2093
P304
P356
10.1126/SCIENCE.3018933
P407
P577
1986-10-01T00:00:00Z